Actively Recruiting

Age: 18Years +
All Genders
NCT04122313

Post-contracture Release Radiation for Dupuytren's Disease

Led by University of Minnesota · Updated on 2026-03-19

50

Participants Needed

1

Research Sites

508 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To determine if the clinical impression of clinicians, ie that patients are improving with the current treatment pathway for Dupuytren's (contracture release followed by radiation), can be substantiated with scientific evidence.

CONDITIONS

Official Title

Post-contracture Release Radiation for Dupuytren's Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnoses of Dupuytren's disease
  • English-speaking
Not Eligible

You will not qualify if you...

  • Patients with Dupuytren's disease who are not currently seeking treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Minnesota

Minneapolis, Minnesota, United States, 55455

Actively Recruiting

Loading map...

Research Team

L

Leslie Chang

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Post-contracture Release Radiation for Dupuytren's Disease | DecenTrialz